Tybost is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with antiretroviral medications. Tybost is also referred to by its drug name, Cobicistat, and by the abbreviation COBI. Cobicistat is a component in the combination medications Evotaz, Prezcobix, Genvoya, and Stribild.
Tybost is a pharmacokinetic enhancer. Tybost is believed to work by preventing the body from breaking down some antiretroviral drugs, increasing their effectiveness.
How do I take it?
Prescribing information states that Tybost is taken once daily.
Tybost comes in tablet form.
The FDA-approved label for Tybost lists common side effects including jaundice and rash.
Rare but serious side effects listed for Tybost include kidney failure.
For more details about this treatment, visit:
Tybost highlights of prescribing information – Gilead
Overview of HIV Treatments – AIDS.gov